IL10 and neoplasm: These cells release anti-inflammatory cytokines, including interleukin-10 (IL-10), transforming growth factor-beta (TGF-β), and other protumor mediators that inhibit effector immune responses and foster a tolerogenic and tumor-supportive milieu (Rajani et al., 2019).